Inhibition of peptidyl-arginine deiminases reverses protein-hypercitrullination and disease in mouse models of multiple sclerosis
Multiple sclerosis (MS) is the most common CNS-demyelinating disease of humans, showing clinical and pathological heterogeneity and a general resistance to therapy. We first discovered that abnormal myelin hypercitrullination, even in normal-appearing white matter, by peptidylarginine deiminases (PA...
Saved in:
Published in | Disease models & mechanisms Vol. 6; no. 2; pp. 467 - 478 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
The Company of Biologists Ltd
01.03.2013
The Company of Biologists Limited The Company of Biologists |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Multiple sclerosis (MS) is the most common CNS-demyelinating disease of humans, showing clinical and pathological heterogeneity and a general resistance to therapy. We first discovered that abnormal myelin hypercitrullination, even in normal-appearing white matter, by peptidylarginine deiminases (PADs) correlates strongly with disease severity and might have an important role in MS progression. Hypercitrullination is known to promote focal demyelination through reduced myelin compaction. Here we report that 2-chloroacetamidine (2CA), a small-molecule, PAD active-site inhibitor, dramatically attenuates disease at any stage in independent neurodegenerative as well as autoimmune MS mouse models. 2CA reduced PAD activity and protein citrullination to pre-disease status. In the autoimmune models, disease induction uniformly induced spontaneous hypercitrullination with citrulline+ epitopes targeted frequently. 2CA rapidly suppressed T cell autoreactivity, clearing brain and spinal cord infiltrates, through selective removal of newly activated T cells. 2CA essentially prevented disease when administered before disease onset or before autoimmune induction, making hypercitrullination, and specifically PAD enzymes, a therapeutic target in MS models and thus possibly in MS. |
---|---|
AbstractList | Multiple sclerosis (MS) is the most common CNS-demyelinating disease of humans, showing clinical and pathological heterogeneity and a general resistance to therapy. We first discovered that abnormal myelin hypercitrullination, even in normal-appearing white matter, by peptidylarginine deiminases (PADs) correlates strongly with disease severity and might have an important role in MS progression. Hypercitrullination is known to promote focal demyelination through reduced myelin compaction. Here we report that 2-chloroacetamidine (2CA), a small-molecule, PAD active-site inhibitor, dramatically attenuates disease at any stage in independent neurodegenerative as well as autoimmune MS mouse models. 2CA reduced PAD activity and protein citrullination to pre-disease status. In the autoimmune models, disease induction uniformly induced spontaneous hypercitrullination with citrulline+ epitopes targeted frequently. 2CA rapidly suppressed T cell autoreactivity, clearing brain and spinal cord infiltrates, through selective removal of newly activated T cells. 2CA essentially prevented disease when administered before disease onset or before autoimmune induction, making hypercitrullination, and specifically PAD enzymes, a therapeutic target in MS models and thus possibly in MS. SUMMARY Multiple sclerosis (MS) is the most common CNS-demyelinating disease of humans, showing clinical and pathological heterogeneity and a general resistance to therapy. We first discovered that abnormal myelin hypercitrullination, even in normal-appearing white matter, by peptidylarginine deiminases (PADs) correlates strongly with disease severity and might have an important role in MS progression. Hypercitrullination is known to promote focal demyelination through reduced myelin compaction. Here we report that 2-chloroacetamidine (2CA), a small-molecule, PAD active-site inhibitor, dramatically attenuates disease at any stage in independent neurodegenerative as well as autoimmune MS mouse models. 2CA reduced PAD activity and protein citrullination to pre-disease status. In the autoimmune models, disease induction uniformly induced spontaneous hypercitrullination with citrulline+ epitopes targeted frequently. 2CA rapidly suppressed T cell autoreactivity, clearing brain and spinal cord infiltrates, through selective removal of newly activated T cells. 2CA essentially prevented disease when administered before disease onset or before autoimmune induction, making hypercitrullination, and specifically PAD enzymes, a therapeutic target in MS models and thus possibly in MS. Summary Multiple sclerosis (MS) is the most common CNS-demyelinating disease of humans, showing clinical and pathological heterogeneity and a general resistance to therapy. We first discovered that abnormal myelin hypercitrullination, even in normal appearing white matter, by peptidylarginine deiminases (PADs) correlates strongly with disease severity and might have an important role in MS progression. Hypercitrullination is known to promote focal demyelination through reduced myelin compaction. Here we report that 2-chloroacetamidine (2CA) a small-molecule, PAD active-site inhibitor, dramatically attenuates disease at any stage in independent neurodegenerative as well as autoimmune MS mouse models. 2CA reduced PAD activity and protein citrullination to pre-disease status. In the autoimmune models, disease induction uniformly induced spontaneous hypercitrullination with citrulline+ epitopes targeted frequently. 2CA rapidly suppressed T cell autoreactivity, clearing brain and spinal cord infiltrates, through selective removal of newly activated T cells. 2CA essentially prevented disease when administered before disease onset or before autoimmune induction, making hypercitrullination and specifically PAD enzymes a therapeutic target in MS models and thus possibly MS. |
Author | Li, Zhen Mastronardi, Fabrizio G Winer, Shawn Tsui, Hubert Ackerley, Cameron Lei, Helena Zhang, Li Wood, D Denise Moscarello, Mario A Raijmakers, Reinout |
AuthorAffiliation | 4 Department of Pathology, The Research Institute, Hospital For Sick Children, Toronto, ON M5G 1X8, Canada 3 Department of Immunology, The Research Institute, Hospital For Sick Children, Toronto, ON M5G 1X8, Canada 6 Department of Biomolecular Chemistry, Nijmegen Center for Molecular Life Sciences and Institute for Molecules and Materials, Radboud University Nijmegen, Nijmegen, The Netherlands 5 Advanced Protein Technology Centre, The Research Institute, Hospital For Sick Children, Toronto, ON M5G 1X8, Canada 2 Inceptium Research and Therapeutics, The Research Institute, Hospital For Sick Children, Toronto, ON M5G 1X8, Canada 1 Molecular Structure and Function, The Research Institute, Hospital For Sick Children, Toronto, ON M5G 1X8, Canada |
AuthorAffiliation_xml | – name: 3 Department of Immunology, The Research Institute, Hospital For Sick Children, Toronto, ON M5G 1X8, Canada – name: 5 Advanced Protein Technology Centre, The Research Institute, Hospital For Sick Children, Toronto, ON M5G 1X8, Canada – name: 2 Inceptium Research and Therapeutics, The Research Institute, Hospital For Sick Children, Toronto, ON M5G 1X8, Canada – name: 1 Molecular Structure and Function, The Research Institute, Hospital For Sick Children, Toronto, ON M5G 1X8, Canada – name: 6 Department of Biomolecular Chemistry, Nijmegen Center for Molecular Life Sciences and Institute for Molecules and Materials, Radboud University Nijmegen, Nijmegen, The Netherlands – name: 4 Department of Pathology, The Research Institute, Hospital For Sick Children, Toronto, ON M5G 1X8, Canada |
Author_xml | – sequence: 1 givenname: Mario A surname: Moscarello fullname: Moscarello, Mario A email: mam@sickkids.ca organization: Molecular Structure and Function, The Research Institute, Hospital For Sick Children, Toronto, ON M5G 1X8, Canada. mam@sickkids.ca – sequence: 2 givenname: Helena surname: Lei fullname: Lei, Helena – sequence: 3 givenname: Fabrizio G surname: Mastronardi fullname: Mastronardi, Fabrizio G – sequence: 4 givenname: Shawn surname: Winer fullname: Winer, Shawn – sequence: 5 givenname: Hubert surname: Tsui fullname: Tsui, Hubert – sequence: 6 givenname: Zhen surname: Li fullname: Li, Zhen – sequence: 7 givenname: Cameron surname: Ackerley fullname: Ackerley, Cameron – sequence: 8 givenname: Li surname: Zhang fullname: Zhang, Li – sequence: 9 givenname: Reinout surname: Raijmakers fullname: Raijmakers, Reinout – sequence: 10 givenname: D Denise surname: Wood fullname: Wood, D Denise |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23118341$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkk-L1DAYxoOsuLujFz-AFLyI0DX_214EWXZ1YMGLnkPavJnJkCY1aRfm6Dc3M7MOrqe-NE9-efLkuUYXIQZA6C3BN4Ry-smM4w0mWFD8Al2RRvC65YRcnGfMLtF1zjuMJW1Z9wpdUkZIyzi5Qr_XYet6N7sYqmirCabZmb2vddq44AJUBtzogs6QqwSPkA7DlOIMLtTb_QRpcHNavC-aI0QHUxmXoeyoXKjGuJRhjAZ8PhwwLn52k4cqDx5SzC6_Ri-t9hnePH1X6Of93Y_bb_XD96_r2y8P9SBYO9ccLIGBE9GyhkvoTSMshZ4aYTijUjILuO0GYIybvuuGVhAtRCuM1Vgz3rEVWp-4JuqdmpIbddqrqJ06_ohpo3SaXbGlSpSCSJCgreRWHrG27U1XcFIQUVifT6xp6UcwA4Q5af8M-nwluK3axEfFRNfg8ggr9OEJkOKvBfKsRpcH8F4HKIkpwkhHGoopKdL3_0l3cUmhRKVosSZJJ5rD7T6eVEMJNSewZzMEq0NLVGmJOrWkiN_9a_8s_VsL9gfgTr1X |
CitedBy_id | crossref_primary_10_1002_ijc_33205 crossref_primary_10_1016_j_bbamem_2016_02_024 crossref_primary_10_1134_S1607672916040116 crossref_primary_10_1016_j_dci_2020_103714 crossref_primary_10_1002_bip_22256 crossref_primary_10_1016_j_bbagrm_2013_07_003 crossref_primary_10_1016_j_bmc_2013_12_064 crossref_primary_10_1111_joim_13045 crossref_primary_10_1002_pmic_201700299 crossref_primary_10_1159_000522331 crossref_primary_10_1016_j_bmc_2017_03_006 crossref_primary_10_1021_ml300377d crossref_primary_10_1111_apha_13869 crossref_primary_10_1186_s40478_022_01433_5 crossref_primary_10_1016_j_cbd_2020_100676 crossref_primary_10_1002_ana_26014 crossref_primary_10_1038_s41598_021_96675_z crossref_primary_10_1186_1742_2094_11_64 crossref_primary_10_1080_14728222_2021_1918104 crossref_primary_10_3389_fimmu_2016_00227 crossref_primary_10_1016_j_cbpa_2016_06_020 crossref_primary_10_1021_jm301755q crossref_primary_10_1002_cmdc_201300557 crossref_primary_10_1016_j_bbamcr_2014_02_018 crossref_primary_10_1016_j_fsi_2020_06_053 crossref_primary_10_1016_j_mehy_2015_01_022 crossref_primary_10_1039_c3md00091e crossref_primary_10_1016_j_snb_2015_12_050 crossref_primary_10_1111_all_12651 crossref_primary_10_1021_acs_jproteome_7b00270 crossref_primary_10_3389_fimmu_2020_00651 crossref_primary_10_1002_pmic_202200286 crossref_primary_10_1007_s10787_023_01149_5 crossref_primary_10_3389_fimmu_2019_00540 crossref_primary_10_1007_s00018_022_04126_3 crossref_primary_10_1007_s12035_017_0560_0 crossref_primary_10_1016_j_celrep_2019_03_108 crossref_primary_10_1002_ardp_201800247 crossref_primary_10_1002_jcp_27874 crossref_primary_10_1021_acs_jmedchem_7b01102 crossref_primary_10_1007_s40496_014_0042_7 crossref_primary_10_1016_j_molmed_2016_07_002 crossref_primary_10_4167_jbv_2013_43_3_159 crossref_primary_10_1007_s11064_016_1920_2 |
Cites_doi | 10.1021/bi00535a016 10.1016/0304-4165(88)90088-8 10.1046/j.1432-1327.1999.00083.x 10.1097/01.jnen.0000225024.12074.80 10.1016/0165-0270(94)90206-2 10.2353/ajpath.2008.080388 10.1084/jem.20100239 10.1002/ana.20016 10.1002/jnr.490360309 10.1523/JNEUROSCI.3349-06.2006 10.1021/bi051341y 10.1002/bip.1974.360130211 10.1084/jem.20072051 10.1093/oxfordjournals.jbchem.a021667 10.1016/j.jaad.2003.09.018 10.1093/oxfordjournals.jbchem.a123636 10.1007/s10495-006-3715-4 10.4049/jimmunol.176.6.3480 10.1002/cne.20527 10.1002/ana.410400106 10.1002/jnr.21329 10.1242/dmm.000729 10.1016/j.clineuro.2005.11.011 10.1016/j.molimm.2008.01.036 10.1002/ana.20913 10.1083/jcb.200806072 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q 10.1055/s-2007-1019128 10.1016/S0006-3495(81)84853-9 10.1111/j.1471-4159.1993.tb03612.x 10.1007/s00401-009-0625-x 10.1016/j.ydbio.2011.04.015 10.1038/nn.3062 10.1002/art.11229 10.1002/glia.1111 10.4049/jimmunol.1103414 10.3109/08916939509008017 10.1046/j.1471-4159.2002.00834.x 10.1177/1352458506072167 10.1172/JCI117300 10.1016/0014-5793(81)80708-9 10.1016/S0021-9258(18)51637-9 10.1167/iovs.05-1499 10.1016/0003-9861(86)90237-7 10.4049/jimmunol.0903639 10.1002/(SICI)1097-4547(19960515)44:4<301::AID-JNR1>3.0.CO;2-G 10.1038/labinvest.3700748 10.4049/jimmunol.172.10.6418 10.1016/S1474-4422(05)70117-4 10.1002/jnr.20431 10.1002/cne.20529 10.1684/ejd.2011.1394 10.1046/j.1471-4159.1995.64030967.x |
ContentType | Journal Article |
Copyright | 2013. This work is licensed under http://creativecommons.org/licenses/by-nc-sa/3.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2013. Published by The Company of Biologists Ltd 2013 |
Copyright_xml | – notice: 2013. This work is licensed under http://creativecommons.org/licenses/by-nc-sa/3.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2013. Published by The Company of Biologists Ltd 2013 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7X7 7XB 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M7P PIMPY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1242/dmm.010520 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection AUTh Library subscriptions: ProQuest Central ProQuest Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection (Proquest) (PQ_SDU_P3) ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) Biological Science Database Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: Open Access: DOAJ - Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1754-8411 |
EndPage | 478 |
ExternalDocumentID | oai_doaj_org_article_052516e6eaf64f689ce3f8bd985d6515 10_1242_dmm_010520 23118341 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | 0R~ 29G 2WC 53G 5GY 5VS 6~0 6~1 7X7 8FI 8FJ AAFWJ ABUWG ADBBV AENEX AFKRA AFPKN AGGIJ AIPOO ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BBNVY BCNDV BENPR BHPHI BTFSW C1A CCPQU CGR CS3 CUY CVF DIK DU5 E3Z EBS ECM EE- EIF EJD F5P F9R FRJ FRP FYUFA GROUPED_DOAJ H13 HCIFZ HMCUK HYE HZ~ INIJC IPNFZ KQ8 M7P M~E NPM O9- OK1 P2P PIMPY RHF RHI RIG RNS RPM TR2 UKHRP W2D W8F AAYXX CITATION 3V. 7XB 8FE 8FH 8FK AZQEC DWQXO GNUQQ K9. LK8 PQEST PQQKQ PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c538t-4ef1ec41583746ebd75f2eb2d5d432663fe089ce334db99c851a5585dfa0a3493 |
IEDL.DBID | RPM |
ISSN | 1754-8403 |
IngestDate | Thu Jul 04 20:53:44 EDT 2024 Tue Sep 17 21:26:36 EDT 2024 Sat Jun 22 21:19:08 EDT 2024 Thu Oct 10 16:13:28 EDT 2024 Fri Aug 23 00:36:17 EDT 2024 Sat Sep 28 07:57:15 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0), which permits unrestricted non-commercial use, distribution and reproduction in any medium provided that the original work is properly cited and all further distributions of the work or adaptation are subject to the same Creative Commons License terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c538t-4ef1ec41583746ebd75f2eb2d5d432663fe089ce334db99c851a5585dfa0a3493 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Present address: Bijvoet Center for Biomedical Research, Utrecht University, 3584 CH Utrecht, The Netherlands |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597028/ |
PMID | 23118341 |
PQID | 2689619579 |
PQPubID | 5510497 |
PageCount | 12 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_052516e6eaf64f689ce3f8bd985d6515 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3597028 proquest_miscellaneous_1319172021 proquest_journals_2689619579 crossref_primary_10_1242_dmm_010520 pubmed_primary_23118341 |
PublicationCentury | 2000 |
PublicationDate | 2013-03-01 |
PublicationDateYYYYMMDD | 2013-03-01 |
PublicationDate_xml | – month: 03 year: 2013 text: 2013-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Cambridge |
PublicationTitle | Disease models & mechanisms |
PublicationTitleAlternate | Dis Model Mech |
PublicationYear | 2013 |
Publisher | The Company of Biologists Ltd The Company of Biologists Limited The Company of Biologists |
Publisher_xml | – name: The Company of Biologists Ltd – name: The Company of Biologists Limited – name: The Company of Biologists |
References | 8687186 - Ann Neurol. 1996 Jul;40(1):18-24 15844172 - J Comp Neurol. 2005 Jun 6;486(3):243-53 6165412 - Biophys J. 1981 May;34(2):345-50 6164577 - FEBS Lett. 1981 Mar 23;125(2):159-60 6176267 - Biochemistry. 1982 Mar 16;21(6):1208-14 15128833 - J Immunol. 2004 May 15;172(10):6418-26 3416014 - Biochim Biophys Acta. 1988 Sep 8;966(3):375-83 17079667 - J Neurosci. 2006 Nov 1;26(44):11387-96 16386359 - Clin Neurol Neurosurg. 2006 Mar;108(3):339-45 2753915 - J Biol Chem. 1989 Aug 5;264(22):13361-8 21697043 - Eur J Dermatol. 2011 May-Jun;21(3):376-84 20164413 - J Immunol. 2010 Mar 15;184(6):2839-46 15844173 - J Comp Neurol. 2005 Jun 6;486(3):254-66 10092850 - Eur J Biochem. 1999 Feb;259(3):660-9 18256987 - Semin Neurol. 2008 Feb;28(1):56-68 7689646 - J Neurochem. 1993 Sep;61(3):987-96 18391064 - J Exp Med. 2008 Apr 14;205(4):967-79 16802293 - Ann Neurol. 2006 Jul;60(1):12-21 18787103 - Am J Pathol. 2008 Oct;173(4):1129-42 15963443 - Lancet Neurol. 2005 Jul;4(7):403-12 16229464 - Biochemistry. 2005 Oct 25;44(42):13744-52 8739149 - J Neurosci Res. 1996 May 15;44(4):301-7 16517716 - J Immunol. 2006 Mar 15;176(6):3480-9 20733033 - J Exp Med. 2010 Aug 30;207(9):1853-62 9192727 - J Biochem. 1997 May;121(5):868-75 15704193 - J Neurosci Res. 2005 Apr 1;80(1):120-8 16502257 - Apoptosis. 2006 Feb;11(2):183-96 7505836 - J Neurosci Res. 1993 Oct 15;36(3):315-24 10852536 - Ann Neurol. 2000 Jun;47(6):707-17 13130468 - Arthritis Rheum. 2003 Sep;48(9):2489-500 16691112 - J Neuropathol Exp Neurol. 2006 Apr;65(4):305-18 2420275 - Arch Biochem Biophys. 1986 Mar;245(2):455-63 11596130 - Glia. 2001 Nov;36(2):220-34 15034502 - J Am Acad Dermatol. 2004 Apr;50(4):533-40 19093029 - Dis Model Mech. 2008 Nov-Dec;1(4-5):229-40 17548438 - Mult Scler. 2007 Jun;13(5):596-609 16723463 - Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2508-14 7518827 - J Clin Invest. 1994 Jul;94(1):146-54 1778991 - J Biochem. 1991 Oct;110(4):661-6 4820066 - Biopolymers. 1974;13(2):359-69 18227806 - Lab Invest. 2008 Apr;88(4):354-64 21539830 - Dev Biol. 2011 Jul 15;355(2):205-14 12064481 - J Neurochem. 2002 Apr;81(2):335-43 8822278 - Autoimmunity. 1995;21(3):203-14 15048884 - Ann Neurol. 2004 Apr;55(4):458-68 7532214 - J Neurochem. 1995 Mar;64(3):967-76 19153223 - J Cell Biol. 2009 Jan 26;184(2):205-13 17469138 - J Neurosci Res. 2007 Jul;85(9):2006-16 18374982 - Mol Immunol. 2008 May;45(10):2808-19 20013286 - Acta Neuropathol. 2010 Feb;119(2):199-210 22366759 - Nat Neurosci. 2012 Apr;15(4):543-50 7723378 - J Neurosci Methods. 1994 Dec;55(2):137-53 22351936 - J Immunol. 2012 Apr 1;188(7):3150-9 Liu (2021042513090303700_b24-0060467) 2006; 11 Kuhn (2021042513090303700_b20-0060467) 2008; 45 Musse (2021042513090303700_b36-0060467) 2008; 1 Ehrlich (2021042513090303700_b10-0060467) 2004; 50 Vossenaar (2021042513090303700_b47-0060467) 2003; 48 Mastronardi (2021042513090303700_b29-0060467) 1996; 44 Locatelli (2021042513090303700_b25-0060467) 2012; 15 Li (2021042513090303700_b23-0060467) 2010; 207 Mastronardi (2021042513090303700_b28-0060467) 1993; 36 Boggs (2021042513090303700_b3-0060467) 1982; 21 Brady (2021042513090303700_b4-0060467) 1981; 125 Moscarello (2021042513090303700_b35-0060467) 2002; 81 Jang (2021042513090303700_b17-0060467) 2008; 173 Brady (2021042513090303700_b5-0060467) 1981; 34 Comi (2021042513090303700_b7-0060467) 2006; 108 Tuohy (2021042513090303700_b46-0060467) 1995; 21 Raijmakers (2021042513090303700_b39-0060467) 2005; 486 Lamensa (2021042513090303700_b21-0060467) 1993; 61 Ludwin (2021042513090303700_b27-0060467) 2006; 65 Stone (2021042513090303700_b42-0060467) 2005; 44 Hemmer (2021042513090303700_b13-0060467) 2005; 4 Johnson (2021042513090303700_b19-0060467) 1995; 64 Wingerchuk (2021042513090303700_b50-0060467) 2008; 28 Iglesias (2021042513090303700_b15-0060467) 2001; 36 Takahara (2021042513090303700_b43-0060467) 1989; 264 Terakawa (2021042513090303700_b44-0060467) 1991; 110 Mastronardi (2021042513090303700_b30-0060467) 2004; 172 Epand (2021042513090303700_b11-0060467) 1974; 13 Barnett (2021042513090303700_b1-0060467) 2004; 55 Steinman (2021042513090303700_b41-0060467) 2006; 60 Mastronardi (2021042513090303700_b33-0060467) 2007; 13 Nishijyo (2021042513090303700_b38-0060467) 1997; 121 Ishigami (2021042513090303700_b16-0060467) 2005; 80 Watanabe (2021042513090303700_b49-0060467) 1988; 966 Rus'd (2021042513090303700_b40-0060467) 1999; 259 Mastronardi (2021042513090303700_b31-0060467) 2006; 26 Nicholas (2021042513090303700_b37-0060467) 2005; 486 Hill (2021042513090303700_b14-0060467) 2008; 205 Zhu (2021042513090303700_b53-0060467) 2006; 176 Lucchinetti (2021042513090303700_b26-0060467) 2000; 47 Mastronardi (2021042513090303700_b32-0060467) 2007; 85 Wang (2021042513090303700_b48-0060467) 2009; 184 Moscarello (2021042513090303700_b34-0060467) 1994; 94 Carrillo-Vico (2021042513090303700_b6-0060467) 2010; 184 Feirabend (2021042513090303700_b12-0060467) 1994; 55 Wood (2021042513090303700_b51-0060467) 1996; 40 Lange (2021042513090303700_b22-0060467) 2011; 355 Deber (2021042513090303700_b9-0060467) 1986; 245 Jang (2021042513090303700_b18-0060467) 2010; 119 Coudane (2021042513090303700_b8-0060467) 2011; 21 Wood (2021042513090303700_b52-0060467) 2008; 88 Bhattacharya (2021042513090303700_b2-0060467) 2006; 47 Tillak (2021042513090303700_b45-0060467) 2012; 188 |
References_xml | – volume: 21 start-page: 1208 year: 1982 ident: 2021042513090303700_b3-0060467 article-title: Effect of pH and fatty acid chain length on the interaction of myelin basic protein with phosphatidylglycerol publication-title: Biochemistry doi: 10.1021/bi00535a016 contributor: fullname: Boggs – volume: 966 start-page: 375 year: 1988 ident: 2021042513090303700_b49-0060467 article-title: Combined biochemical and immunochemical comparison of peptidylarginine deiminases present in various tissues publication-title: Biochim. Biophys. Acta doi: 10.1016/0304-4165(88)90088-8 contributor: fullname: Watanabe – volume: 259 start-page: 660 year: 1999 ident: 2021042513090303700_b40-0060467 article-title: Molecular cloning of cDNAs of mouse peptidylarginine deiminase type I, type III and type IV, and the expression pattern of type I in mouse publication-title: Eur. J. Biochem. doi: 10.1046/j.1432-1327.1999.00083.x contributor: fullname: Rus'd – volume: 65 start-page: 305 year: 2006 ident: 2021042513090303700_b27-0060467 article-title: The pathogenesis of multiple sclerosis: relating human pathology to experimental studies publication-title: J. Neuropathol. Exp. Neurol. doi: 10.1097/01.jnen.0000225024.12074.80 contributor: fullname: Ludwin – volume: 55 start-page: 137 year: 1994 ident: 2021042513090303700_b12-0060467 article-title: Preservation of myelinated fibers for electron microscopy: a qualitative comparison of aldehyde fixation, microwave stabilisation and other procedures all completed by osmication publication-title: J. Neurosci. Methods doi: 10.1016/0165-0270(94)90206-2 contributor: fullname: Feirabend – volume: 173 start-page: 1129 year: 2008 ident: 2021042513090303700_b17-0060467 article-title: Accumulation of citrullinated proteins by up-regulated peptidylarginine deiminase 2 in brains of scrapie-infected mice: a possible role in pathogenesis publication-title: Am. J. Pathol. doi: 10.2353/ajpath.2008.080388 contributor: fullname: Jang – volume: 207 start-page: 1853 year: 2010 ident: 2021042513090303700_b23-0060467 article-title: PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps publication-title: J. Exp. Med. doi: 10.1084/jem.20100239 contributor: fullname: Li – volume: 55 start-page: 458 year: 2004 ident: 2021042513090303700_b1-0060467 article-title: Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion publication-title: Ann. Neurol. doi: 10.1002/ana.20016 contributor: fullname: Barnett – volume: 36 start-page: 315 year: 1993 ident: 2021042513090303700_b28-0060467 article-title: Demyelination in a transgenic mouse: a model for multiple sclerosis publication-title: J. Neurosci. Res. doi: 10.1002/jnr.490360309 contributor: fullname: Mastronardi – volume: 26 start-page: 11387 year: 2006 ident: 2021042513090303700_b31-0060467 article-title: Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: a role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.3349-06.2006 contributor: fullname: Mastronardi – volume: 44 start-page: 13744 year: 2005 ident: 2021042513090303700_b42-0060467 article-title: Inactivation of two diverse enzymes in the amidinotransferase superfamily by 2-chloroacetamidine: dimethylargininase and peptidylarginine deiminase publication-title: Biochemistry doi: 10.1021/bi051341y contributor: fullname: Stone – volume: 13 start-page: 359 year: 1974 ident: 2021042513090303700_b11-0060467 article-title: Circular dichroism and proton magnetic resonance studies of random chain poly-L-lysine publication-title: Biopolymers doi: 10.1002/bip.1974.360130211 contributor: fullname: Epand – volume: 205 start-page: 967 year: 2008 ident: 2021042513090303700_b14-0060467 article-title: Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice publication-title: J. Exp. Med. doi: 10.1084/jem.20072051 contributor: fullname: Hill – volume: 121 start-page: 868 year: 1997 ident: 2021042513090303700_b38-0060467 article-title: Isolation and molecular cloning of epidermal- and hair follicle-specific peptidylarginine deiminase (type III) from rat publication-title: J. Biochem. doi: 10.1093/oxfordjournals.jbchem.a021667 contributor: fullname: Nishijyo – volume: 50 start-page: 533 year: 2004 ident: 2021042513090303700_b10-0060467 article-title: Micellar paclitaxel improves severe psoriasis in a prospective phase II pilot study publication-title: J. Am. Acad. Dermatol. doi: 10.1016/j.jaad.2003.09.018 contributor: fullname: Ehrlich – volume: 110 start-page: 661 year: 1991 ident: 2021042513090303700_b44-0060467 article-title: Three types of mouse peptidylarginine deiminase: characterization and tissue distribution publication-title: J. Biochem. doi: 10.1093/oxfordjournals.jbchem.a123636 contributor: fullname: Terakawa – volume: 11 start-page: 183 year: 2006 ident: 2021042513090303700_b24-0060467 article-title: Overexpression of peptidylarginine deiminase IV features in apoptosis of hematopoietic cells publication-title: Apoptosis doi: 10.1007/s10495-006-3715-4 contributor: fullname: Liu – volume: 176 start-page: 3480 year: 2006 ident: 2021042513090303700_b53-0060467 article-title: Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis publication-title: J. Immunol. doi: 10.4049/jimmunol.176.6.3480 contributor: fullname: Zhu – volume: 486 start-page: 254 year: 2005 ident: 2021042513090303700_b37-0060467 article-title: Expression of citrullinated proteins in murine experimental autoimmune encephalomyelitis publication-title: J. Comp. Neurol. doi: 10.1002/cne.20527 contributor: fullname: Nicholas – volume: 40 start-page: 18 year: 1996 ident: 2021042513090303700_b51-0060467 article-title: Acute multiple sclerosis (Marburg type) is associated with developmentally immature myelin basic protein publication-title: Ann. Neurol. doi: 10.1002/ana.410400106 contributor: fullname: Wood – volume: 85 start-page: 2006 year: 2007 ident: 2021042513090303700_b32-0060467 article-title: Peptidyl argininedeiminase 2 CpG island in multiple sclerosis white matter is hypomethylated publication-title: J. Neurosci. Res. doi: 10.1002/jnr.21329 contributor: fullname: Mastronardi – volume: 1 start-page: 229 year: 2008 ident: 2021042513090303700_b36-0060467 article-title: Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous system publication-title: Dis. Model. Mech. doi: 10.1242/dmm.000729 contributor: fullname: Musse – volume: 108 start-page: 339 year: 2006 ident: 2021042513090303700_b7-0060467 article-title: MS treatment: new perspectives publication-title: Clin. Neurol. Neurosurg. doi: 10.1016/j.clineuro.2005.11.011 contributor: fullname: Comi – volume: 45 start-page: 2808 year: 2008 ident: 2021042513090303700_b20-0060467 article-title: Complement receptor CR2/CR1 deficiency protects mice from collagen-induced arthritis and associates with reduced autoantibodies to type II collagen and citrullinated antigens publication-title: Mol. Immunol. doi: 10.1016/j.molimm.2008.01.036 contributor: fullname: Kuhn – volume: 60 start-page: 12 year: 2006 ident: 2021042513090303700_b41-0060467 article-title: How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis publication-title: Ann. Neurol. doi: 10.1002/ana.20913 contributor: fullname: Steinman – volume: 184 start-page: 205 year: 2009 ident: 2021042513090303700_b48-0060467 article-title: Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation publication-title: J. Cell Biol. doi: 10.1083/jcb.200806072 contributor: fullname: Wang – volume: 47 start-page: 707 year: 2000 ident: 2021042513090303700_b26-0060467 article-title: Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination publication-title: Ann. Neurol. doi: 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q contributor: fullname: Lucchinetti – volume: 28 start-page: 56 year: 2008 ident: 2021042513090303700_b50-0060467 article-title: Current evidence and therapeutic strategies for multiple sclerosis publication-title: Semin. Neurol. doi: 10.1055/s-2007-1019128 contributor: fullname: Wingerchuk – volume: 34 start-page: 345 year: 1981 ident: 2021042513090303700_b5-0060467 article-title: The effect of basic myelin protein on multilayer membrane formation publication-title: Biophys. J. doi: 10.1016/S0006-3495(81)84853-9 contributor: fullname: Brady – volume: 61 start-page: 987 year: 1993 ident: 2021042513090303700_b21-0060467 article-title: Deimination of human myelin basic protein by a peptidylarginine deiminase from bovine brain publication-title: J. Neurochem. doi: 10.1111/j.1471-4159.1993.tb03612.x contributor: fullname: Lamensa – volume: 119 start-page: 199 year: 2010 ident: 2021042513090303700_b18-0060467 article-title: Involvement of peptidylarginine deiminase-mediated post-translational citrullination in pathogenesis of sporadic Creutzfeldt-Jakob disease publication-title: Acta Neuropathol. doi: 10.1007/s00401-009-0625-x contributor: fullname: Jang – volume: 355 start-page: 205 year: 2011 ident: 2021042513090303700_b22-0060467 article-title: Protein deiminases: new players in the developmentally regulated loss of neural regenerative ability publication-title: Dev. Biol. doi: 10.1016/j.ydbio.2011.04.015 contributor: fullname: Lange – volume: 15 start-page: 543 year: 2012 ident: 2021042513090303700_b25-0060467 article-title: Primary oligodendrocyte death does not elicit anti CNS immunity publication-title: Nat. Neurosci. doi: 10.1038/nn.3062 contributor: fullname: Locatelli – volume: 48 start-page: 2489 year: 2003 ident: 2021042513090303700_b47-0060467 article-title: Citrullination of synovial proteins in murine models of rheumatoid arthritis publication-title: Arthritis Rheum. doi: 10.1002/art.11229 contributor: fullname: Vossenaar – volume: 36 start-page: 220 year: 2001 ident: 2021042513090303700_b15-0060467 article-title: T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis publication-title: Glia doi: 10.1002/glia.1111 contributor: fullname: Iglesias – volume: 188 start-page: 3150 year: 2012 ident: 2021042513090303700_b45-0060467 article-title: T-Lymphocyte priming of neutrophil extracellular traps links innate and adaptive immune responses publication-title: J. Immunol. doi: 10.4049/jimmunol.1103414 contributor: fullname: Tillak – volume: 21 start-page: 203 year: 1995 ident: 2021042513090303700_b46-0060467 article-title: Determinant-regulated onset of experimental autoimmune encephalomyelitis: distinct epitopes of myelin proteolipid protein mediate either acute or delayed disease in SJL/J mice publication-title: Autoimmunity doi: 10.3109/08916939509008017 contributor: fullname: Tuohy – volume: 81 start-page: 335 year: 2002 ident: 2021042513090303700_b35-0060467 article-title: Peptidylarginine deiminase: a candidate factor in demyelinating disease publication-title: J. Neurochem. doi: 10.1046/j.1471-4159.2002.00834.x contributor: fullname: Moscarello – volume: 13 start-page: 596 year: 2007 ident: 2021042513090303700_b33-0060467 article-title: Synergy between paclitaxel plus an exogenous methyl donor in the suppression of murine demyelinating diseases publication-title: Mult. Scler. doi: 10.1177/1352458506072167 contributor: fullname: Mastronardi – volume: 94 start-page: 146 year: 1994 ident: 2021042513090303700_b34-0060467 article-title: Myelin in multiple sclerosis is developmentally immature publication-title: J. Clin. Invest. doi: 10.1172/JCI117300 contributor: fullname: Moscarello – volume: 125 start-page: 159 year: 1981 ident: 2021042513090303700_b4-0060467 article-title: The interaction of basic proteins from normal and multiple sclerosis myelin with phosphatidylglycerol vesicles publication-title: FEBS Lett. doi: 10.1016/0014-5793(81)80708-9 contributor: fullname: Brady – volume: 264 start-page: 13361 year: 1989 ident: 2021042513090303700_b43-0060467 article-title: Peptidylarginine deiminase of the mouse. Distribution, properties, and immunocytochemical localization publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)51637-9 contributor: fullname: Takahara – volume: 47 start-page: 2508 year: 2006 ident: 2021042513090303700_b2-0060467 article-title: Proteomics implicates peptidyl arginine deiminase 2 and optic nerve citrullination in glaucoma pathogenesis publication-title: Invest. Ophthalmol. Vis. Sci. doi: 10.1167/iovs.05-1499 contributor: fullname: Bhattacharya – volume: 245 start-page: 455 year: 1986 ident: 2021042513090303700_b9-0060467 article-title: Binding of human normal and multiple sclerosis-derived myelin basic protein to phospholipid vesicles: effects on membrane head group and bilayer regions publication-title: Arch. Biochem. Biophys. doi: 10.1016/0003-9861(86)90237-7 contributor: fullname: Deber – volume: 184 start-page: 2839 year: 2010 ident: 2021042513090303700_b6-0060467 article-title: Contribution of myelin autoantigen citrullination to T cell autoaggression in the central nervous system publication-title: J.Immunol. doi: 10.4049/jimmunol.0903639 contributor: fullname: Carrillo-Vico – volume: 44 start-page: 301 year: 1996 ident: 2021042513090303700_b29-0060467 article-title: Loss of myelin basic protein cationicity in DM20 transgenic mice is dosage dependent publication-title: J. Neurosci. Res. doi: 10.1002/(SICI)1097-4547(19960515)44:4<301::AID-JNR1>3.0.CO;2-G contributor: fullname: Mastronardi – volume: 88 start-page: 354 year: 2008 ident: 2021042513090303700_b52-0060467 article-title: Myelin localization of peptidylarginine deiminases 2 and 4: comparison of PAD2 and PAD4 activities publication-title: Lab. Invest. doi: 10.1038/labinvest.3700748 contributor: fullname: Wood – volume: 172 start-page: 6418 year: 2004 ident: 2021042513090303700_b30-0060467 article-title: Attenuation of experimental autoimmune encephalomyelitis and nonimmune demyelination by IFN-beta plus vitamin B12: treatment to modify notch-1/sonic hedgehog balance publication-title: J. Immunol. doi: 10.4049/jimmunol.172.10.6418 contributor: fullname: Mastronardi – volume: 4 start-page: 403 year: 2005 ident: 2021042513090303700_b13-0060467 article-title: Immune response to immunotherapy: the role of neutralising antibodies to interferon beta in the treatment of multiple sclerosis publication-title: Lancet Neurol. doi: 10.1016/S1474-4422(05)70117-4 contributor: fullname: Hemmer – volume: 80 start-page: 120 year: 2005 ident: 2021042513090303700_b16-0060467 article-title: Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease publication-title: J. Neurosci. Res. doi: 10.1002/jnr.20431 contributor: fullname: Ishigami – volume: 486 start-page: 243 year: 2005 ident: 2021042513090303700_b39-0060467 article-title: Citrullination of central nervous system proteins during the development of experimental autoimmune encephalomyelitis publication-title: J. Comp. Neurol. doi: 10.1002/cne.20529 contributor: fullname: Raijmakers – volume: 21 start-page: 376 year: 2011 ident: 2021042513090303700_b8-0060467 article-title: Deimination and expression of peptidylarginine deiminases during cutaneous wound healing in mice publication-title: Eur. J. Dermatol. doi: 10.1684/ejd.2011.1394 contributor: fullname: Coudane – volume: 64 start-page: 967 year: 1995 ident: 2021042513090303700_b19-0060467 article-title: Over-expression of the DM-20 myelin proteolipid causes central nervous system demyelination in transgenic mice publication-title: J. Neurochem. doi: 10.1046/j.1471-4159.1995.64030967.x contributor: fullname: Johnson |
SSID | ssj0062839 |
Score | 2.350489 |
Snippet | Multiple sclerosis (MS) is the most common CNS-demyelinating disease of humans, showing clinical and pathological heterogeneity and a general resistance to... Summary Multiple sclerosis (MS) is the most common CNS-demyelinating disease of humans, showing clinical and pathological heterogeneity and a general... SUMMARY Multiple sclerosis (MS) is the most common CNS-demyelinating disease of humans, showing clinical and pathological heterogeneity and a general... |
SourceID | doaj pubmedcentral proquest crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 467 |
SubjectTerms | Amidines - chemistry Amidines - pharmacology Amidines - therapeutic use Animals Apoptosis Binding sites Brain Brain - enzymology Brain - pathology CD3 Complex - metabolism Citrulline - metabolism Demyelinating Diseases - enzymology Demyelinating Diseases - pathology Disease Models, Animal Encephalomyelitis, Autoimmune, Experimental - drug therapy Encephalomyelitis, Autoimmune, Experimental - enzymology Encephalomyelitis, Autoimmune, Experimental - pathology Enzyme Inhibitors - chemistry Enzyme Inhibitors - pharmacology Enzyme Inhibitors - therapeutic use Enzymes Humans Hydrolases - antagonists & inhibitors Hydrolases - metabolism Lymphocytes - drug effects Lymphocytes - pathology Mice Mice, Inbred C57BL Mice, Transgenic Multiple sclerosis Multiple Sclerosis - drug therapy Multiple Sclerosis - enzymology Multiple Sclerosis - pathology Optic Nerve - drug effects Optic Nerve - pathology Optic Nerve - ultrastructure Pathogenesis Peptides Protein expression Protein-Arginine Deiminases Proteins Spleen - drug effects Spleen - metabolism Spleen - pathology Survival Analysis |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJRAXBOUVKMgIrqZdv7I-AqIqSOVEpd4sP8ZsJOpWTS898s-ZcbKrXYTEhWscbZyZsWe-9eT7GHuHGNmYXmfhQEmhexlFLBpELinBMtmSmxjM6Td7cqa_npvzLakv6gmb6IEnwx2SztrCgoVQrC526RKosozZLU0mGe-2-y7MGkxNe7DFpOnap5BGC4QwaiYmxXx0mC8u3pMsJCl8b6Wixtj_tzLzz27JrfRz_JA9mOtG_mGa7yN2B-o-uzspSd7us3un8xn5Y_brS10NsXVi8cvCr6htJd_-FOH6B4lBAM_QlLxGGDnxN1ETB290DUMVK4Sl14m-xCCu7uY1Hmrm8zkOHyqn_wqANwWdkR6wbknkI04MX3QYn7Cz48_fP52IWWhBJNzvboSGsoCEqRzRqrYQc2-KRMidTdZY3llV4KgZXukcnUtYpQWDOCOXcBSUduop26uXFZ4znrKRNltwMUjdJ4QrrsigQ3QJfwlMx96ube6vJj4NTzgEPePRM37yTMc-kjs2dxAHdruAkeHnyPD_ioyOHayd6eeFOXqJ9yFmNL3r2JvNMC4pOicJFdCEfqEIxEqsfjr2bPL9ZiZYDuMmqHGk34mKnanujtRh1Wi7FRoDq7kX_-PdXrL7sulyUDPcAdvDsIBXWB3dxNdtIfwGarcQyg priority: 102 providerName: Directory of Open Access Journals – databaseName: AUTh Library subscriptions: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagFYgLKuUVaJERXE27ju2sT4hWrQpSK4So1Fvk2ONupDa7bHrpkX_OjOMsXYR6jaNk4s-eh2cyH2MfMUbWulJBWCilUJVsRBMViBC9h6k3MSQymNMzc3Kuvl3oi3zg1ueyylEnJkUd5p7OyPekmVp09nVlPy9-CWKNouxqptB4yDblRFGadvPg6Oz7j1EXGzSeNv0SqZXAUKbMDUrRLu2F6-tPRA9JTN93TFLq3P8_d_Pfqsk7Zuh4iz3N_iP_MgD-jD2Abps9Ghglb7fZ49OcK3_Ofn_tZm2TKrL4PPIFla-E2yvhlpdECgE8QGL06qHn1MeJijl4atvQdmKG4enS0x8Z1LM7ocddF3jO5_C243RmADwx6fT0grE0kfcoGH5o279g58dHPw9PRCZcEB713o1QECfg0aRj1KoMNKHSUWLoHXRQ6OaZMsL-1HooSxUaaz16a05jvBGi23elsuVLttHNO3jNuA9ammDANk6qymPYYqN0yjXW45NAF-zDOOf1YuirUVM8gsjUiEw9IFOwA4JjdQf1wk4X5svLOm-tmpj4JgYMuGhUNEnAOG2CRcGI6L1gOyOYdd6gff13ORXs_WoYtxblS1wHOIX1pKRgVqIXVLBXA_YrSdAtRmWocKRaWxVroq6PdO0ste8ucTLQq3tzv1hv2ROZmDeo3G2HbSDgsIv-z03zLi_yPxHkCeo priority: 102 providerName: ProQuest |
Title | Inhibition of peptidyl-arginine deiminases reverses protein-hypercitrullination and disease in mouse models of multiple sclerosis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/23118341 https://www.proquest.com/docview/2689619579 https://search.proquest.com/docview/1319172021 https://pubmed.ncbi.nlm.nih.gov/PMC3597028 https://doaj.org/article/052516e6eaf64f689ce3f8bd985d6515 |
Volume | 6 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB61RSAuCAoUQ4kWwXWbZl_OHmnVqiClqhCVcrPW-2gsNZso7qVH_jmzazsiiBNXP8eeWc983m_nA_iCGFnKUjiqPWdUlKymdRCeumCtn1oVXBaDmV2rq1vxfS7neyCHtTCZtG_r5iTeL09is8jcyvXSjgee2Phmds6xCsa8ON6H_ZLzAaJ3n1-F-VLnVZBSUEQvvO9Jiqlo7JbLk6QIyZL-GxY2GM5ispOQct_-fxWbf3Mm_0hCly_hRV89kq-dla9gz8dDeNrpST4ewrNZP1P-Gn59i4umznwssgpkncgr7vGems1dkoTwxPms59X6lqQuTonKQXLThibSBYLTjU3rMVLH7uw7YqIj_WwOaSJJfww8yTo6bbrBQEwkLRqGD9q0b-D28uLn-RXt5Raoxa_eAxU-TLzFhI6YVShfu1IGhsDbSSewyFM8-NOptp5z4WqtLdZqRiLacMGcGi40fwsHcRX9OyDWSaac8ro2TJQW3aUDM8LU2uKVvCzg8_DOq3XXVaNKaASdVKGTqs5JBZwld2yPSJ2w84bV5q7q46FKOnwT5ZU3QYmgsoFhWjuNhiWZ9wKOB2dW_fBsK4bHIXKUpS7g03Y3Dqw0W2Kix1dYTXiCsgxroAKOOt9vLRlip4ByJyp2TN3dg7Gcm3f3sfv-v8_8AM9ZluRIPLhjOMBY8B-xMHqoRzgc5uUInpxdXN_8GOXfC6M8OH4Dx38UyA |
link.rule.ids | 230,315,733,786,790,870,891,2115,12083,21416,27955,27956,31752,31753,33777,33778,43343,43838,53825,53827,74100,74657 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LbxMxELYgFY8LgvLoQgEjuJo2u7Z3fUIUtUqhiRBqpd4srx_NSnSTZnvpkX_OjNcbGoS4xtFm4rFn5rNnv4-QD4CRhSi5Y8oXOeNlXrM6cM9csNZXVgYXxWCmMzk541_PxXk6cOtSW-UQE2OgdguLZ-R7uawUFPuiVJ-WVwxVo_B2NUlo3CVbSLlZjcjWweHs-48hFktIniq-Eik4AyhTJIJSyEt77vLyI8pDotL3rZQUmfv_VW7-3TV5Kw0dPSaPUv1IP_cOf0Lu-Hab3OsVJW-2yf1puit_Sn4dt_Omjh1ZdBHoEttX3M1PZlYXKArhqfNR0avzHUUeJ2zmoJG2oWnZHODpyuIbGcjZHb1HTetous-hTUvxzMDTqKTT4Q8MrYm0A8PgjzbdM3J2dHj6ZcKS4AKzEPeuGfdh7C2kdECtXPralSLkAL2dcBzKPFkEv18p64uCu1opC9WaEYA3XDD7puCqeE5G7aL1O4RaJ3LppFe1yXlpAbaokBtuamXhSV5k5P0w53rZ82poxCPgGQ2e0b1nMnKA7lh_A7mw4weL1YVOW0ujEt9YeulNkDzIaGCoaqfAMBR6z8ju4EydNmin_yynjLxbD8PWwvsS03qYQj0uEMzmUAVl5EXv-7UlUBZDMOQwUm6sig1TN0faZh7puwuYDKjqXv7frLfkweR0eqJPjmffXpGHeVThwNa3XTIC5_vXUAtd12_Sgv8NzD4M4A |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Pb9MwFLZgiInLBANGxwAjuJq2ie3UJ8SvagM2cWBSb5ZjP6-RWFqaXXbkP-c9xy0rQlzjKHnxZ_u9z355H2OvkSMrVckgDJSFkFVRizpKECF6DxOvY0hiMKdn-vhcfp6pWc5_6nJa5XpNTAt1WHjaIx8WemIw2FeVGcacFvHt4_Tt8qcgBSk6ac1yGrfZHfSSI5JxqGYb8qXRjZr0c6SSAklNmUuVoocahsvLNyQUSZrfN5xTquH_r8Dz7_zJGw5pep_t5UiSv-uhf8BuQbvP7vbaktf7bPc0n5o_ZL9O2nlTp9wsvoh8SYks4fqHcKsLkocAHiBpe3XQcaroRGkdPBVwaFoxR6K68vRvBlXvTjhy1waeT3Z403LaPQCeNHU6esE6SZF3aBh-aNM9YufTT98_HIssvSA8roBXQkIcg0fnjvxVaqhDpWKBJDyoIDHg02WE0cR4KEsZamM8xm1OIfMI0Y1cKU35mO20ixaeMO6DKnTQYGpXyMojgTGxcNLVxuOTQA3Yq3Wf22VfYcMSM0FkLCJje2QG7D3BsbmDqmKnC4vVhc2TzJIm31iDBhe1jDoZGCd1MGgYSb4P2NEaTJunamf_DKwBe7lpxklGJyeuBexCOy6J1hYYDw3YQY_9xhIMkHFZlNhSbY2KLVO3W9pmngp5l9gZGN8d_t-sF2wXR7r9enL25Sm7VyQ5DsqBO2I7iD08w6Doqn6eRvtvejYPnQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Inhibition+of+peptidyl-arginine+deiminases+reverses+protein-hypercitrullination+and+disease+in+mouse+models+of+multiple+sclerosis&rft.jtitle=Disease+models+%26+mechanisms&rft.au=Moscarello%2C+Mario+A&rft.au=Lei%2C+Helena&rft.au=Mastronardi%2C+Fabrizio+G&rft.au=Winer%2C+Shawn&rft.date=2013-03-01&rft.eissn=1754-8411&rft.volume=6&rft.issue=2&rft.spage=467&rft.epage=478&rft_id=info:doi/10.1242%2Fdmm.010520&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1754-8403&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1754-8403&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1754-8403&client=summon |